Brian Pinker, a dialysis patient, received the jab at 7.30am on Monday from Sam Foster, a nurse at Oxford University hospitals NHS foundation trust's Churchill hospital. "I look forward to celebrating my 48th wedding anniversary with my wife Shirley later this year". "The overall vaccine efficacy was found to be 70.42 per cent", Somani said.
"That's a triumph of British science that we've managed to get where we are", Hancock told Sky.
It paves the way for the roll out of at least two vaccines in the country in the coming days.
Covishield is expected to get more use in India as it can be stored and transported under normal refrigeration while the Pfizer shot needs ultra-low temperatures for storage.
Six hospitals in England will administer the first of around 530,000 doses Britain has ready.
The Joint Committee on Vaccination and Immunisation (JCVI) has recommended that as many people as possible in the top priority groups should be offered a first vaccine dose as the initial priority.
The World Health Organisation on Thursday granted emergency validation to the Pfizer-BioNTech vaccine, paving the way for countries worldwide to quickly approve its import and distribution.
Other Western countries have taken a longer and more cautious approach to rolling out vaccines, though Russian Federation and China have been inoculating their citizens for months with several different vaccines still undergoing late-stage trials.
He said that the company also has been barred from selling the vaccine on the private market. The first vaccines are given in a limited number of hospitals for monitoring purposes for the first few days, with standard practice, high Global Positioning System late in the week.
"It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India!" he said on Twitter, calling it a sign of a "self-reliant" country.
Meanwhile, the Thai health ministry said in a statement on Sunday that it was set to receive the first shipment of anti-coronavirus vaccines produced by Chinese firm Sinovac next month, as part of a plan to procure two million doses between February and April. More than 149,000 people have died in India, third behind the USA (347,000) and Brazil (195,000).
But the PM has warned tougher virus rules may be needed in the short-term.
Health Secretary Abdul Mannan, at the same briefing, said: "The new decision from Serum Institute of India will not affect our contract as we have done it through G2G [government to government buying] process".
Boris Johnson said regional restrictions in England are "probably about to get tougher" as the United Kingdom struggles to control a new, fast-spreading variant of the virus. The vaccine manufacturer is likely to charge a special price of ₹200 per dose for the first 100 million jabs which it will supply to the Government of India.
"This is a really critical moment".
- Trump threatens GA official, Senate runoffs on Tuesday
- Tesla Was So Close to Delivering 500,000 Vehicles in 2020
- Samsung to introduce Galaxy M02s in India for price below ₹10,000
- Rohit Sharma Takes Diving Catches During Team India's Training Session
- Bills Will Host The Indianapolis Colts For Home Playoff Game
- Texas A&M runs past North Carolina in Orange Bowl, 41-27
- Trending stat: Bruno is second to which ex-Red?
- U.S. may halve Moderna`s vaccine doses to inoculate more people
- World Health Organization lists Pfizer vaccine for emergency use
- Treasury Begins Disbursement of $600 Stimulus Payments